No overview information available.
No background information available.
用于风湿及类风湿关节炎,各种骨质增生。颈椎病,骨质疏松及软骨病,退行性病变,如股骨头坏死、肋骨骨炎,促进骨折及骨伤科术后愈合。
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H20060085 | 注射剂 | N/A | 10mg多肽 | Chemical Drug | Approved | 2020/10/14 | Domestic | ||
国药准字H20051237 | 注射剂 | 唛金沥 | 25mg多肽 | Chemical Drug | Approved | 2020/10/26 | Domestic | ||
国药准字H20051050 | 注射剂 | N/A | 100ml:多肽物质0.1g与氯化钠0.9g | Chemical Drug | Approved | 2020/12/07 | Domestic | ||
国药准字H20051236 | 注射剂 | 唛金沥 | 100ml:多肽0.1g与氯化钠0.87g | Chemical Drug | Approved | 2020/10/27 | Domestic | ||
国药准字H20060032 | 注射剂 | N/A | 25mg | Chemical Drug | Approved | 2020/05/11 | Domestic | ||
国药准字H20040524 | 注射剂 | N/A | 10mg | Chemical Drug | Approved | 2020/05/11 | Domestic | ||
国药准字H20060033 | 注射剂 | N/A | 50mg | Chemical Drug | Approved | 2020/05/11 | Domestic | ||
国药准字S20053019 | 片剂 | N/A | 0.3g | Chemical Drug | Approved | 2020/04/08 | Domestic | ||
国药准字H32020002 | 片剂 | N/A | 0.3g | Chemical Drug | Approved | 2020/07/21 | Domestic | ||
国药准字H20055876 | 片剂 | N/A | 每片含多肽类物质不低于40mg | Chemical Drug | Approved | 2020/03/31 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug